CNSP
$1.00
Cns Pharmaceuticals
($.08)
(7.01%)
CNSP
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.31)
Revenue:  N/A
Friday
Feb 11
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when CNSP reports earnings?
Beat
Meet
Miss

Where is CNSP's stock price going from here?
Up
Flat
Down
Stock chart of CNSP
Analysts
Summary of analysts' recommendations for CNSP
Score
Grade
Pivots
Resistance
$1.12
$1.09
$1.04

$1.01

Support
$0.96
$0.93
$0.88
Tweet
Growth
Description
CNS Pharmaceuticals Inc. is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors. The company's lead drug includes Berubicin, for the treatment of Glioblastoma Multiforme and potentially for other CNS malignancies. CNS Pharmaceuticals Inc. is based in Houston, United States.